n/a: n/a

Myriad Genetics, Inc. (MYGN: NASDAQ)

$15.66 n/a | n/a%
01/20/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 15.46
52 Week High 40.34
52 Week Low 15.37
Avg. Daily Vol. (Mil) 1.25
Beta (3 year) -0.14
Share Related Items
Mkt Cap (Mil) 1,057.72
Shares Out (Mil) 68.42
Float (Mil) 48.04
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.90
Current Ratio 1.20
LT Debt/ Equity 0.00
Total Debt / Equity 0.27
Valuation Ratios
Price Earnings 11.70
Price/Sales 1.41
Price/Book 1.44
Price/Cash Flow 8.40
Per Share Data
Earnings 1.32
Sales 10.93
Book Value 10.75
Cash Flow 1.85
Business Summary
Myriad Genetics Inc is a molecular diagnostic company. It develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests. It also provides physicians with information to solve unmet medical needs.
General Information
320 Wakara Way
Salt Lake City, UT 84108
Industry : Diversified Services
Sector: Services
Employees: 2206
CEO: Mr. Mark Christopher Cap
Short Interest
Current Month (Mil) 21.86
Previous Month (Mil) 21.41
Short Interest Ratio (Days) 21.30
Management Effectiveness
Return on Equity 13.20
Return on Assets 7.70
Return on Investments 13.20
Gross Margin 82.40
EBIT Margin 17.30
Profit Margin 13.00

Portfolios with MYGN

Latest MYGN Headlines from TheStreet

More Financial News for MYGN

Press Releases for MYGN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter